<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue archivearticle.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName archivearticle.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Emerging Infect. Dis</journal-id><journal-id journal-id-type="publisher-id">EID</journal-id><journal-title-group><journal-title>Emerging Infectious Diseases</journal-title></journal-title-group><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control and Prevention</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6106438</article-id><article-id pub-id-type="pmid">30124196</article-id><article-id pub-id-type="publisher-id">17-1709</article-id><article-id pub-id-type="doi">10.3201/eid2409.171709</article-id><article-categories><subj-group subj-group-type="heading"><subject>Synopsis</subject></subj-group><subj-group subj-group-type="article-type"><subject>Synopsis</subject></subj-group><subj-group subj-group-type="TOC-title"><subject>Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers</subject></subj-group></article-categories><title-group><article-title>Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers</article-title><alt-title alt-title-type="running-head">Postexposure Prophylaxis for CCHFV</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Erg&#x000f6;n&#x000fc;l</surname><given-names>&#x000d6;nder</given-names></name></contrib><contrib contrib-type="author"><name><surname>Keske</surname><given-names>&#x0015e;iran</given-names></name></contrib><contrib contrib-type="author"><name><surname>&#x000c7;eldir</surname><given-names>Melis G&#x000f6;k&#x000e7;e</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kara</surname><given-names>&#x00130;layda Arjen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pshenichnaya</surname><given-names>Natalia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Abuova</surname><given-names>Gulzhan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Blumberg</surname><given-names>Lucille</given-names></name></contrib><contrib contrib-type="author"><name><surname>G&#x000f6;nen</surname><given-names>Mehmet</given-names></name></contrib><aff id="aff1">Ko&#x000e7; University, Istanbul, Turkey (&#x000d6;. Erg&#x000f6;n&#x000fc;l, M.G. &#x000c7;eldir, &#x00130;.A. Kara, M. G&#x000f6;nen); </aff><aff id="aff2">American Hospital, Istanbul (&#x0015e;. Keske); Rostov State Medical University, Rostov-on-Don, Russia (N. Pshenichnaya); </aff><aff id="aff3">South-Kazakhstan State Pharmaceutical Academy, Shymkent, Kazakhstan (G. Abuova); </aff><aff id="aff4">National Institute for Communicable Diseases, Johannesburg, South Africa (L. Blumberg)</aff></contrib-group><author-notes><corresp id="cor1">Address for correspondence: &#x000d6;nder Erg&#x000f6;n&#x000fc;l, Ko&#x000e7; University, School of Medicine, Infectious Diseases Department, Davutpa&#x0015f;a Caddesi, No. 4, 34010 Topkapi, Istanbul, Turkey; email: <email xlink:href="oergonul@ku.edu.tr">oergonul@ku.edu.tr</email></corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2018</year></pub-date><volume>24</volume><issue>9</issue><fpage>1642</fpage><lpage>1648</lpage><abstract><p>We performed a systematic review and meta-analysis on the effectiveness of ribavirin use for the prevention of infection and death of healthcare workers exposed to patients with Crimean-Congo hemorrhagic fever virus (CCHFV) infection. Splashes with blood or bodily fluids (odds ratio [OR] 4.2), being a nurse or physician (OR 2.1), and treating patients who died from CCHFV infection (OR 3.8) were associated with healthcare workers acquiring CCHFV infection; 7% of the workers who received postexposure prophylaxis (PEP) with ribavirin and 89% of those who did not became infected. PEP with ribavirin reduced the odds of infection (OR 0.01, 95% CI 0&#x02013;0.03), and ribavirin use <underline>&#x0003c;</underline>48 hours after symptom onset reduced the odds of death (OR 0.03, 95% CI 0&#x02013;0.58). The odds of death increased 2.4-fold every day without ribavirin treatment. Ribavirin should be recommended as PEP and early treatment for workers at medium-to-high risk for CCHFV infection.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>Crimean-Congo hemorrhagic fever</kwd><kwd>ribavirin</kwd><kwd>healthcare workers</kwd><kwd>postexposure prophylaxis</kwd><kwd>early treatment</kwd><kwd>CCHF</kwd><kwd>viral hemorrhagic fever</kwd><kwd>PRISMA</kwd><kwd>meta-analysis</kwd><kwd>viruses</kwd><kwd>vector-borne infections</kwd><kwd>zoonoses</kwd><kwd>systematic review</kwd><kwd>Crimean-Congo hemorrhagic fever virus</kwd><kwd>CCHFV</kwd><kwd>Turkey</kwd><kwd>Pakistan</kwd><kwd>Germany</kwd><kwd>Iran</kwd><kwd>India</kwd><kwd>South Africa</kwd><kwd>Russia</kwd><kwd>Tajikistan</kwd><kwd>Arabic Emirates</kwd><kwd>Mauritania</kwd><kwd>Kazakhstan</kwd><kwd>Sudan</kwd><kwd>Albania</kwd><kwd>and Spain</kwd></kwd-group></article-meta></front><body><p>Crimean-Congo hemorrhagic fever (CCHF) virus (CCHFV) is listed as a highly infectious pathogen that could cause a public health emergency (<ext-link ext-link-type="uri" xlink:href="http://www.who.int/medicines/ebola-treatment/WHO-list-of-top-emerging-diseases/en/">http://www.who.int/medicines/ebola-treatment/WHO-list-of-top-emerging-diseases/en/</ext-link>). CCHFV infection has been reported from &#x0003e;30 countries in Africa, Asia, Europe, and the Middle East (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>,<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>). CCHFV is a member of the genus <italic>Orthonairovirus</italic> in the family <italic>Nairoviridae</italic> that causes severe disease in humans; the reported case fatality rate is 3%&#x02013;30% (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>). Humans can become infected through the bites of ticks, by contact with patient blood or bodily fluids, or by contact with blood or tissues from viremic livestock. The risk for human-to-human transmission of CCHFV increases in parallel with the lack of preparedness (<xref rid="R3" ref-type="bibr"><italic>3</italic></xref>).</p><p>Healthcare workers need to be well prepared against the emerging threat of CCHF outbreaks. The efficacy of postexposure prophylaxis (PEP) with ribavirin for high-risk exposures to CCHFV needs clear evidence. The relatively low secondary attack rates of CCHFV and ethics constraints make controlled, prospective efficacy trials for ribavirin PEP unlikely. In the absence of efficacy studies, a thorough examination and logical extrapolation of the existing data can be useful for developing recommendations. The efficacy of PEP for healthcare workers exposed to CCHF patients might be similar to that for healthcare workers with high-risk exposures to Lassa fever patients (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>). A series of cases of healthcare workers infected with CCHFV has been reported (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>&#x02013;<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>). Integration of the details on the exposures and the outcomes of the infections from these published reports could provide the opportunity to generate powerful conclusions about the risk for infection and death among healthcare workers. We described the efficacy of PEP with ribavirin for CCHFV infection and early ribavirin use in CCHF treatment.</p><sec sec-type="methods"><title>Methods</title><sec><title>Search Strategy</title><p>We performed a systematic review of individual participant data (IPD) and reported data by using PRISMA-IPD (Preferred Reporting Items for Systematic Reviews and Meta-Analyses for IPD) guidelines (<xref rid="R11" ref-type="bibr"><italic>11</italic></xref>). We searched PubMed, Google, ProMED, and conference proceedings by using the keywords &#x0201c;Crimea-Congo hemorrhagic fever,&#x0201d; &#x0201c;health care worker,&#x0201d; &#x0201c;nosocomial,&#x0201d; &#x0201c;CCHF,&#x0201d; and &#x0201c;health professional.&#x0201d; We included all published reports in peer-reviewed journals through September 3, 2017.</p></sec><sec><title>Definitions and Outcome of Interest</title><p>We defined CCHFV exposure as visible contact or imperceptible contact (i.e., contact with patient aerosols) with a CCHF patient. Primary outcomes were infection with no symptoms, infection with symptoms, and death. The primary study objective was to assess the protective role of PEP and early ribavirin treatment. Early treatment was defined as treatment occurring <underline>&#x0003c;</underline>48 hours after the onset of symptoms.</p></sec><sec><title>Exposure Risk Groups</title><p>Healthcare workers were grouped into 3 categories with respect to their risks for CCHFV infection. The high-risk group consisted of healthcare workers who were directly exposed to blood or bodily fluids of a CCHFV-infected patient, such as through a needle stick or splash. Healthcare workers in this group were categorized as being without personal protective equipment (PPE) of any sort by default because a PPE breach had occurred. The moderate-risk group comprised healthcare workers without a known direct exposure to blood or bodily fluids of a CCHFV-infected patient but either handled patients who bleed or visibly produced other body fluids or were involved in aerosol-producing procedures (e.g., intubation, bronchoscopy, and resuscitation) without wearing an N95 mask. The low- or unknown-risk group consisted of healthcare workers who cared for CCHFV-infected patients who did not actively bleed or produce bodily fluids and did not participate in aerosol-producing procedures.</p></sec><sec><title>Inclusion and Exclusion Criteria</title><p>In this study, we included healthcare workers who were exposed to CCHFV through a defined transmission event who did and did not receive PEP, healthcare workers with laboratory-confirmed CCHFV infections who had a detailed exposure history and were closely followed by laboratory tests for their clinical outcomes, and symptomatic healthcare workers who did and did not receive ribavirin <underline>&#x0003c;</underline>48 hours after the onset of symptoms. In the reports from Albania (<xref rid="R12" ref-type="bibr"><italic>12</italic></xref>,<xref rid="R13" ref-type="bibr"><italic>13</italic></xref>), Pakistan (<xref rid="R14" ref-type="bibr"><italic>14</italic></xref>,<xref rid="R15" ref-type="bibr"><italic>15</italic></xref>), South Africa (<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>,<xref rid="R16" ref-type="bibr"><italic>16</italic></xref>,<xref rid="R17" ref-type="bibr"><italic>17</italic></xref>), and India (<xref rid="R18" ref-type="bibr"><italic>18</italic></xref>,<xref rid="R19" ref-type="bibr"><italic>19</italic></xref>), some of the cases were duplicates (included in &#x0003e;1 article). In these instances, we avoided duplicated data and selected the case information from the earlier publication for inclusion. We did not include seroprevalence studies, gray literature, or screening reports for tracing cases that did not have defined exposures; if the information was incomplete or lacking, we requested the information directly from the authors, and we did not include the articles if the data we needed were unavailable.</p></sec><sec><title>Data Collection</title><p>We entered IPD obtained from reports into a structured data sheet. We performed analyses using an integrated dataset in Stata version 11 (<ext-link ext-link-type="uri" xlink:href="https://www.stata.com/">https://www.stata.com/</ext-link>). In our dataset, we included information on demographics, transmission, PEP, the course of infection, the number of days from onset of disease, and treatment. The dataset also included information on the predictors of infection and death. Study authors (&#x000d6;.E., &#x0015e;.K., M.G.&#x000c7;., and &#x00130;.A.K.) resolved discrepancies during discussions with local physicians.</p></sec><sec><title>Statistical Analysis</title><p>We followed the PRISMA-IPD statement guidelines (<xref rid="R11" ref-type="bibr"><italic>11</italic></xref>) using R studio (<ext-link ext-link-type="uri" xlink:href="https://www.rstudio.com/">https://www.rstudio.com/</ext-link>). We used a 2-stage approach for analyses. First, we analyzed the studies that were suitable for calculating an effect estimate (odds ratio [OR]). Then, we pooled all the participant studies, including single case reports, and calculated a common effect estimate (OR) and 95% CI. We used random effects models.</p></sec><sec><title>Bias Assessment</title><p>We performed an analysis for confounders with the integrated dataset. We used the &#x003c7;<sup>2</sup> test for categorical data and <italic>t</italic>-test for continuous data and performed logistic regression to detect potential confounding predictors of infection and death. To predict infection, we included in our model the covariates PEP with ribavirin, being in the high-risk group, being a nurse or physician, and providing care for a CCHF patient who died. To predict death, we included in our model the covariates days from onset of symptoms to ribavirin treatment, being in the high-risk group, and being a nurse or physician. These were the most critical variables for predicting death. In statistical analyses, we used Stata version 11, and we considered p values &#x0003c;0.05 statistically significant. For meta-analysis, we used meta: General Package for Meta-Analysis version 4.9-1 (<ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/meta/index.html">https://cran.r-project.org/web/packages/meta/index.html</ext-link>).</p></sec></sec><sec sec-type="results"><title>Results</title><p>We reviewed 1,224 published reports on CCHF, and 33 studies met our inclusion criteria (<xref ref-type="fig" rid="F1">Figure 1</xref>). In the included studies, 175 healthcare workers from Turkey (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>,<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>,<xref rid="R20" ref-type="bibr"><italic>20</italic></xref>&#x02013;<xref rid="R25" ref-type="bibr"><italic>25</italic></xref>), Pakistan (<xref rid="R15" ref-type="bibr"><italic>15</italic></xref>,<xref rid="R26" ref-type="bibr"><italic>26</italic></xref>&#x02013;<xref rid="R32" ref-type="bibr"><italic>32</italic></xref>), Germany (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>), Iran (<xref rid="R33" ref-type="bibr"><italic>33</italic></xref>&#x02013;<xref rid="R36" ref-type="bibr"><italic>36</italic></xref>), India (<xref rid="R18" ref-type="bibr"><italic>18</italic></xref>,<xref rid="R19" ref-type="bibr"><italic>19</italic></xref>), South Africa (<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>), Russia (<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>), Tajikistan (<xref rid="R37" ref-type="bibr"><italic>37</italic></xref>), United Arab Emirates (<xref rid="R38" ref-type="bibr"><italic>38</italic></xref>), Mauritania (<xref rid="R39" ref-type="bibr"><italic>39</italic></xref>), Kazakhstan (<xref rid="R40" ref-type="bibr"><italic>40</italic></xref>), Sudan (<xref rid="R41" ref-type="bibr"><italic>41</italic></xref>,<xref rid="R42" ref-type="bibr"><italic>42</italic></xref>), Albania (<xref rid="R12" ref-type="bibr"><italic>12</italic></xref>), and Spain (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>) were exposed to patients infected with CCHFV (<xref rid="T1" ref-type="table">Table</xref>). We included all of the healthcare workers who were infected, but because of the lack of detailed exposure histories among those who were not infected, we excluded 47 healthcare workers from Tajikistan (<xref rid="R37" ref-type="bibr"><italic>37</italic></xref>), 75 from Turkey (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>,<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>), 40 from Germany (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>), and 33 from Pakistan (<xref rid="R15" ref-type="bibr"><italic>15</italic></xref>,<xref rid="R30" ref-type="bibr"><italic>30</italic></xref>). The diagnoses were based on reverse transcription PCR results for 58 (57%) healthcare workers, ELISA for 47 (46%), both ELISA and reverse transcription PCR for 26 (25%), immunofluorescence assay for 13 (12%), and complement fixation for 10 (10%).</p><fig id="F1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>Identification and selection of studies included in a meta-analysis of the effectiveness of postexposure prophylaxis with ribavirin and early treatment with ribavirin among healthcare workers exposed to patients infected with Crimean-Congo hemorrhagic fever virus, 1976&#x02013;2017. IPD, individual participant data.</p></caption><graphic xlink:href="17-1709-F1"/></fig><table-wrap id="T1" position="float"><label>Table</label><caption><title>Characteristics and outcomes for healthcare workers exposed to patients with Crimean-Congo hemorrhagic fever virus infection, 1976&#x02013;2017</title></caption><table frame="hsides" rules="groups"><col width="135" span="1"/><col width="54" span="1"/><col width="58" span="1"/><col width="63" span="1"/><col width="72" span="1"/><col width="49" span="1"/><col width="50" span="1"/><thead><tr><th rowspan="2" valign="bottom" align="left" scope="col" colspan="1">Country (references)</th><th valign="bottom" colspan="6" align="center" scope="colgroup" rowspan="1">No. (%)<hr/></th></tr><tr><th valign="bottom" colspan="1" align="center" scope="colgroup" rowspan="1">Exposed, N&#x000a0;=&#x000a0;175</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">High risk, n&#x000a0;=&#x000a0;107</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Moderate risk, n&#x000a0;=&#x000a0;65</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Low or no known risk, n = 3</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Infected, n&#x000a0;=&#x000a0;102</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Died, n&#x000a0;=&#x000a0;34</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Turkey (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref><italic>,</italic><xref rid="R7" ref-type="bibr"><italic>7</italic></xref><italic>,</italic><xref rid="R20" ref-type="bibr"><italic>20</italic></xref><italic>&#x02013;</italic><xref rid="R25" ref-type="bibr"><italic>25</italic></xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">49 (28)</td><td valign="top" align="center" rowspan="1" colspan="1">23 (22)</td><td valign="top" align="center" rowspan="1" colspan="1">26 (40)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">19 (19)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Pakistan (<xref rid="R15" ref-type="bibr"><italic>15</italic></xref><italic>,</italic><xref rid="R26" ref-type="bibr"><italic>26</italic></xref><italic>&#x02013;</italic><xref rid="R32" ref-type="bibr"><italic>32</italic></xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">45 (26)</td><td valign="top" align="center" rowspan="1" colspan="1">21 (20)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (36)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">18 (18)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (18)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Germany (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (10)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (17)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Iran (<xref rid="R33" ref-type="bibr"><italic>33</italic></xref><italic>&#x02013;</italic><xref rid="R36" ref-type="bibr"><italic>36</italic></xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (9)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (2)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (33)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (12)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">India (<xref rid="R18" ref-type="bibr"><italic>18</italic></xref><italic>,</italic><xref rid="R19" ref-type="bibr"><italic>19</italic></xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (5)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (5)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (5)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (18)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Russia (<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (5)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (6)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">2 (67)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">South Africa (<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (5)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (8)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Tajikistan (<xref rid="R37" ref-type="bibr"><italic>37</italic></xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (4)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">7 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">United Arab Emirates (<xref rid="R38" ref-type="bibr"><italic>38</italic></xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (3)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (6)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">5 (5)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Kazakhstan (<xref rid="R40" ref-type="bibr"><italic>40</italic></xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (3)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (3)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">5 (5)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mauritania (<xref rid="R39" ref-type="bibr"><italic>39</italic></xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (3)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (5)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">5 (5)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (15)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sudan (<xref rid="R41" ref-type="bibr"><italic>41</italic></xref><italic>,</italic><xref rid="R42" ref-type="bibr"><italic>42</italic></xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (2)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (2)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Albania (<xref rid="R12" ref-type="bibr"><italic>12</italic></xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Spain (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1)</td><td valign="top" align="center" rowspan="1" colspan="1">(1)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr></tbody></table></table-wrap><p>The population of healthcare workers included in our study was 53% male and 47% female. The percentages of infected male and female healthcare workers did not differ (p = 0.828), and the percentage of symptomatic male (38%) and female (29%) healthcare workers who died was not significantly different (p = 0.413). Among symptomatic healthcare workers, the mean age was 33 (SD 8.5, range 20&#x02013;61) years, and the case-fatality rate was 34%. The percentage of symptomatic cases did not differ from the percentage of asymptomatic cases (p = 0.545), and the case-fatality rate was not higher in symptomatic than asymptomatic healthcare workers (p = 0.674). Being a nurse or physician (p = 0.01) and caring for a CCHF patient who died (94% of infected healthcare workers vs. 80% of noninfected healthcare workers; p = 0.006) were factors more common among healthcare workers who were infected than those who were not.</p><p>We performed 2 meta-analyses: 1 on the effectiveness of PEP with ribavirin to prevent CCHFV infection (<xref ref-type="fig" rid="F2">Figure 2</xref>, panel A) and 1 on the effectiveness of early ribavirin treatment after CCHF symptom onset to prevent death (<xref ref-type="fig" rid="F2">Figure 2</xref>, panel B). In the first stage of the meta-analysis on PEP, the OR could be calculated for only 4 studies (OR 0.05, 95% CI 0.01&#x02013;0.26); at the second stage, after pooling all healthcare worker study data, the OR was 0.01 (95% CI 0&#x02013;0.03; <xref ref-type="fig" rid="F2">Figure 2</xref>, panel A). The heterogeneity of these studies was not significant (I<sup>2</sup>&#x000a0;=&#x000a0;3%, &#x00393;<sup>2</sup>&#x000a0;=&#x000a0;0.1157; p = 0.38). During the first stage of the meta-analysis on early ribavirin use, the OR could be calculated for only 2 studies (OR 0.04, 95% CI 0&#x02013;1.33); at the second stage of the analysis, after pooling all healthcare worker study data, the OR was 0.03 (95% CI 0&#x02013;0.58; <xref ref-type="fig" rid="F2">Figure 2</xref>, panel B). No heterogeneity was detected among these studies (I<sup>2</sup>&#x000a0;=&#x000a0;0%, &#x00393;<sup>2</sup>&#x000a0;=&#x000a0;0; p = 0.92).</p><fig id="F2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>Effectiveness of PEP and early treatment with ribavirin among healthcare workers exposed to patients infected with Crimean-Congo hemorrhagic fever virus, 1976&#x02013;2017. A) Two-step meta-analysis of the effectiveness of PEP with ribavirin for preventing Crimean-Congo hemorrhagic fever virus infection. We could determine the effect estimates for only 4 individual studies, and we included 33 reports in the final pooled estimate. B) Two-step meta-analysis on the effectiveness of early ribavirin use for preventing death caused by Crimean-Congo hemorrhagic fever virus infection. We could determine the effect estimate for only 2 individual studies, and we included 33 reports in the final pooled estimate. OR, odds ratio; PEP, postexposure prophylaxis.</p></caption><graphic xlink:href="17-1709-F2"/></fig><p>In univariate analyses of healthcare workers exposed to CCHF patients, splashes with blood or bodily fluids (OR 4.2, 95% CI 2.04&#x02013;9.7; p&#x0003c;0.001), being a nurse or physician (OR 2.1, 95% CI 1.13&#x02013;4.1; p = 0.019), and caring for a patient who died (OR 3.8, 95% CI 1.38&#x02013;10.46; p = 0.01) significantly increased the odds of a healthcare worker acquiring an infection. However, PEP with ribavirin significantly reduced the risk for CCHFV infection (OR 0.01, 95% CI 0.003&#x02013;0.03; p&#x0003c;0.001). To control for confounders, we performed a multivariate analysis of the data set. In multivariate analyses of exposed healthcare workers, PEP with ribavirin was found to significantly protect against CCHFV infection (OR 0.009, 95% CI 0.001&#x02013;0.039; p&#x0003c;0.001). In a sensitivity analysis, the area under the receiver operating curve was 94%. In a multivariate analysis of symptomatic healthcare workers adjusted by risk group (high risk vs. others) and worker type (nurse or physician vs. others), the risk for death increased 2.4-fold for every day of delay in the start of ribavirin treatment (OR 2.4, 95% CI 1.27&#x02013;4.56; p = 0.005). Appropriate use of PPE and PEP with ribavirin predicted death completely; therefore, both of these factors were not included in the model. The sensitivity of this model, calculated by the area under the receiver operating curve, was 95%.</p><p>Of 175 healthcare workers exposed to CCHF patients, 55 (31%) received and 110 (63%) did not receive PEP with ribavirin (<xref ref-type="fig" rid="F3">Figure 3</xref>). In the PEP arm, 7% acquired infection, and in the no PEP arm, 89% acquired infection (p&#x0003c;0.001; <xref ref-type="fig" rid="F3">Figure 3</xref>). In the no PEP arm, 97 (99%) of 98 infected healthcare workers became symptomatic. None of the symptomatic healthcare workers who received ribavirin within 48 hours after the onset of symptoms died, whereas 42% of the symptomatic healthcare workers who did not receive ribavirin within 48 hours died (p&#x0003c;0.001; <xref ref-type="fig" rid="F3">Figure 3</xref>). Among symptomatic healthcare workers who received ribavirin, the median time from onset of symptoms to ribavirin treatment was 5 days for those who died and 1.25 days for those who survived (p&#x0003c;0.001).</p><fig id="F3" fig-type="figure" position="float"><label>Figure 3</label><caption><p>Flowchart of healthcare workers exposed to patients infected with Crimean-Congo hemorrhagic fever virus who did and did not receive PEP with ribavirin or early ribavirin treatment <underline>&#x0003c;</underline>48 hours after symptom onset, 1976&#x02013;2017. *Healthcare workers for which PEP information was not included in the original report. PEP, postexposure prophylaxis.</p></caption><graphic xlink:href="17-1709-F3"/></fig><p>For 104 (59.4%) of 175 healthcare workers, the appropriateness of the PPE was assessed by the authors of the original report. The percentage who became infected was lower for those who used PPE appropriately (55%) than those who did not (70%), although this difference was not significant (p = 0.301). No fatal cases were reported among those who used PPE appropriately. In all reports, the PPE used included a mask, gloves, and a gown; in 1 study in Germany (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>), the additional use of goggles was reported.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>We analyzed all published reports on healthcare workers who were exposed to CCHF patients and had a moderate-to-high risk of acquiring a CCHFV infection. These cases represent the case density in the 14 countries included, in parallel with previous reports (<xref rid="R43" ref-type="bibr"><italic>43</italic></xref>,<xref rid="R44" ref-type="bibr"><italic>44</italic></xref>). Most cases were from Turkey, Pakistan, and Iran. However, healthcare workers could acquire the infection from persons from other countries (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>), and in 2017, a nurse in Spain acquired (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>) a CCHFV infection from a patient with an autochthonous case.</p><p>We determined that PEP with ribavirin reduced CCHFV infection among healthcare workers and early ribavirin use reduced death among CCHFV-infected healthcare workers (<xref ref-type="fig" rid="F2">Figure 2</xref>). In most case series and case reports, no healthcare workers died who received PEP with ribavirin (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>&#x02013;<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>,<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>), including those who received PEP soon after a high-risk incident (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p><p>Early use of ribavirin in the treatment of CCHFV infection has been reported as beneficial (<xref rid="R45" ref-type="bibr"><italic>45</italic></xref>,<xref rid="R46" ref-type="bibr"><italic>46</italic></xref>) and is considered to be beneficial, despite a controversial report (<xref rid="R47" ref-type="bibr"><italic>47</italic></xref>). In the report in which authors disagreed with ribavirin use being beneficial, the authors did not account for the starting time of ribavirin treatment after symptom onset, even though this factor can significantly alter its efficacy. Close follow-up of infected healthcare workers provides an opportunity to determine the efficacy of early ribavirin use; assessing the quality of treatments given to exposed healthcare workers is much more feasible than assessing that of patients with suspected CCHF transferred from rural areas. In this study, we showed that every day of treatment delay increases the risk for death by 2.4-fold. Of note, none of the symptomatic healthcare workers who received ribavirin within 48 hours after the onset of symptoms died, whereas 42% of those who did not receive treatment in that time frame died (p&#x0003c;0.001; <xref ref-type="fig" rid="F3">Figure 3</xref>). Late diagnosis of the source case can result in delayed PEP and treatment of healthcare workers with ribavirin (<xref rid="R21" ref-type="bibr"><italic>21</italic></xref>,<xref rid="R30" ref-type="bibr"><italic>30</italic></xref>).</p><p>Some centers have reported aerosol CCHFV transmission (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>&#x02013;<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>,<xref rid="R33" ref-type="bibr"><italic>33</italic></xref>,<xref rid="R48" ref-type="bibr"><italic>48</italic></xref>). A number of procedures (e.g., bronchoscopy, nasal tamponade, intubation, cardiopulmonary resuscitation) as well as patient bleeding can lead to the aerosolization of CCHFV. Persons near CCHFV patients during these activities should be considered at moderate risk for acquiring the infection. Awareness of transmission after percutaneous injuries is high, but healthcare workers with imperceptible exposures to aerosolized pathogens should also be considered for close follow-up. Our study findings indicate that PEP with ribavirin should be recommended for those with CCHFV exposures, similar to the recommendations for healthcare workers with Lassa virus exposures (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>).</p><p>In this study, we included all published reports of detailed, laboratory-confirmed cases; we avoided duplicated cases and excluded screenings of healthcare workers with nonspecified risk (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>,<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>,<xref rid="R15" ref-type="bibr"><italic>15</italic></xref>,<xref rid="R28" ref-type="bibr"><italic>28</italic></xref>,<xref rid="R49" ref-type="bibr"><italic>49</italic></xref>,<xref rid="R50" ref-type="bibr"><italic>50</italic></xref>). One limitation of this study is reporting bias; we did not include unreported cases. Because of medical and legal issues, some fatal cases involving healthcare workers who were not using PPE appropriately or who did not receive PEP might not have been reported. For example, 2 fatal cases involving healthcare workers who were not given ribavirin, 1 from Turkey (<ext-link ext-link-type="uri" xlink:href="http://www.hurriyet.com.tr/gundem/kan-alirken-eline-igne-batan-kubra-kkka-dan-oldu-11861967">http://www.hurriyet.com.tr/gundem/kan-alirken-eline-igne-batan-kubra-kkka-dan-oldu-11861967</ext-link>) and 1 from Pakistan (<ext-link ext-link-type="uri" xlink:href="https://www.samaa.tv/uncategorized/2016/07/congo-fever-cases-emerge-in-bahawalpur/">https://www.samaa.tv/uncategorized/2016/07/congo-fever-cases-emerge-in-bahawalpur/</ext-link>), were not published in the literature, but their stories appeared in the media. Even though we received detailed information about these cases, we did not include them in our study because they were not published in peer-reviewed journals. These unreported fatal cases support the use of ribavirin for PEP and early treatment, as we recommend in this report.</p><p>Another limitation of this study was regarding the reporting of the appropriateness of the PPE used, which was reported for only &#x02248;60% of the healthcare workers included. PPE use is not standardized; appropriate use varies substantially from country to country. For instance, in a study in Germany, the use of surgical masks instead of N95 masks during aerosol-generating procedures is considered inappropriate (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>); however, this practice was considered appropriate in many other studies. Implementing standard use of PPE in healthcare settings is urgently needed. Our study shows that N95 masks should be used in high- and moderate-risk events, including those involving contact with patients who are bleeding or visibly generating bodily fluids or aerosols.</p><p>Our analyses were performed by using an integrated dataset that included all necessary detailed information about the demographics, transmission, PEP, course of the infection, days from onset of disease, and treatment. This dataset could be supplied to researchers in the field and used as a tool for future investigations.</p><p>In conclusion, our results indicate a significant beneficial effect of PEP with ribavirin after CCHFV exposure. This beneficial effect extended to early use of ribavirin for treatment of infected healthcare workers. Imperceptible contact with infectious particles and splashes of blood or bodily fluids from infected patients should all be considered and prevented. A universal standard of care that includes PPE and PEP and treatment with ribavirin should be implemented for healthcare workers at risk for CCHF.</p></sec></body><back><fn-group><fn fn-type="citation"><p><italic>Suggested citation for this article</italic>: Erg&#x000f6;n&#x000fc;l &#x000d6;, Keske &#x0015e;, &#x000c7;eldir MG, Kara &#x00130;A, Pshenichnaya N, Abuova G, et al. Systematic review and meta-analysis of postexposure prophylaxis for Crimean-Congo hemorrhagic fever virus among healthcare workers. Emerg Infect Dis. 2018 Sep [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid2409.171709">https://doi.org/10.3201/eid2409.171709</ext-link></p></fn></fn-group><ack><p>M.G. was supported by the Turkish Academy of Sciences (T&#x000dc;BA-GEB&#x00130;P, the Young Scientist Award Program) and the Science Academy of Turkey (BAGEP, the Young Scientist Award Program).</p></ack><bio id="d35e1019"><p>Dr. Erg&#x000f6;n&#x000fc;l is professor of infectious disease and clinical microbiology at Ko&#x000e7; University School of Medicine in Istanbul, Turkey. His primary research interests include emerging infections.</p></bio><ref-list><title>References</title><ref id="R1"><label>1. </label><mixed-citation publication-type="journal"><string-name><surname>Erg&#x000f6;n&#x000fc;l</surname>
<given-names>O</given-names></string-name>. <article-title>Crimean-Congo haemorrhagic fever.</article-title>
<source>Lancet Infect Dis</source>. <year>2006</year>;<volume>6</volume>:<fpage>203</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(06)70435-2</pub-id><?supplied-pmid 16554245?><pub-id pub-id-type="pmid">16554245</pub-id></mixed-citation></ref><ref id="R2"><label>2. </label><mixed-citation publication-type="journal"><string-name><surname>Negredo</surname>
<given-names>A</given-names></string-name>, <string-name><surname>de la Calle-Prieto</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Palencia-Herrej&#x000f3;n</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Mora-Rillo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Astray-Mochales</surname>
<given-names>J</given-names></string-name>, <string-name><surname>S&#x000e1;nchez-Seco</surname>
<given-names>MP</given-names></string-name>, <etal>et al.</etal>; <collab>Crimean Congo Hemorrhagic Fever@Madrid Working Group</collab>. <article-title>Autochthonous Crimean-Congo hemorrhagic fever in Spain.</article-title>
<source>N Engl J Med</source>. <year>2017</year>;<volume>377</volume>:<fpage>154</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1615162</pub-id><?supplied-pmid 28700843?><pub-id pub-id-type="pmid">28700843</pub-id></mixed-citation></ref><ref id="R3"><label>3. </label><mixed-citation publication-type="book"><string-name><surname>Tarantola</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ergonul</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Tattevin</surname>
<given-names>P</given-names></string-name>. Estimates and prevention of Crimean-Congo hemorrhagic fever risks for health-care workers. In: Ergonul O, Whitehouse CA, editors. Crimean-Congo hemorrhagic fever: a global perspective. Dordrecht (the Netherlands): Springer; <year>2007</year>. p. 281&#x02013;94.</mixed-citation></ref><ref id="R4"><label>4. </label><mixed-citation publication-type="journal"><string-name><surname>Bausch</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Hadi</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Khan</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Lertora</surname>
<given-names>JJ</given-names></string-name>. <article-title>Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever.</article-title>
<source>Clin Infect Dis</source>. <year>2010</year>;<volume>51</volume>:<fpage>1435</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1086/657315</pub-id><?supplied-pmid 21058912?><pub-id pub-id-type="pmid">21058912</pub-id></mixed-citation></ref><ref id="R5"><label>5. </label><mixed-citation publication-type="journal"><string-name><surname>Celikbas</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Dokuzo&#x0011f;uz</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Baykam</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Gok</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Ero&#x0011f;lu</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Midilli</surname>
<given-names>K</given-names></string-name>, <etal>et al.</etal>
<article-title>Crimean-Congo hemorrhagic fever among health care workers, Turkey.</article-title>
<source>Emerg Infect Dis</source>. <year>2014</year>;<volume>20</volume>:<fpage>477</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3201/eid2003.131353</pub-id><?supplied-pmid 24564994?><pub-id pub-id-type="pmid">24564994</pub-id></mixed-citation></ref><ref id="R6"><label>6. </label><mixed-citation publication-type="journal"><string-name><surname>Conger</surname>
<given-names>NG</given-names></string-name>, <string-name><surname>Paolino</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Osborn</surname>
<given-names>EC</given-names></string-name>, <string-name><surname>Rusnak</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>G&#x000fc;nther</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pool</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal>
<article-title>Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009.</article-title>
<source>Emerg Infect Dis</source>. <year>2015</year>;<volume>21</volume>:<fpage>23</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.3201/eid2101.141413</pub-id><?supplied-pmid 25529825?><pub-id pub-id-type="pmid">25529825</pub-id></mixed-citation></ref><ref id="R7"><label>7. </label><mixed-citation publication-type="journal"><string-name><surname>Guner</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Hasanoglu</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Tasyaran</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Yapar</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Keske</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Guven</surname>
<given-names>T</given-names></string-name>, <etal>et al.</etal>
<article-title>Is ribavirin prophylaxis effective for nosocomial transmission of Crimean-Congo hemorrhagic fever?</article-title>
<source>Vector Borne Zoonotic Dis</source>. <year>2014</year>;<volume>14</volume>:<fpage>601</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1089/vbz.2013.1546</pub-id><?supplied-pmid 25072991?><pub-id pub-id-type="pmid">25072991</pub-id></mixed-citation></ref><ref id="R8"><label>8. </label><mixed-citation publication-type="journal"><string-name><surname>Pshenichnaya</surname>
<given-names>NY</given-names></string-name>, <string-name><surname>Nenadskaya</surname>
<given-names>SA</given-names></string-name>. <article-title>Probable Crimean-Congo hemorrhagic fever virus transmission occurred after aerosol-generating medical procedures in Russia: nosocomial cluster.</article-title>
<source>Int J Infect Dis</source>. <year>2015</year>;<volume>33</volume>:<fpage>120</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2014.12.047</pub-id><?supplied-pmid 25576827?><pub-id pub-id-type="pmid">25576827</pub-id></mixed-citation></ref><ref id="R9"><label>9. </label><mixed-citation publication-type="journal"><string-name><surname>Richards</surname>
<given-names>GA</given-names></string-name>. <article-title>Nososcomial transmission of viral haemorrhagic fever in South Africa.</article-title>
<source>S Afr Med J</source>. <year>2015</year>;<volume>105</volume>:<fpage>709</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.7196/SAMJnew.8168</pub-id><?supplied-pmid 26428962?><pub-id pub-id-type="pmid">26428962</pub-id></mixed-citation></ref><ref id="R10"><label>10. </label><mixed-citation publication-type="journal"><string-name><surname>Leblebicioglu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Sunbul</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Guner</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bodur</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Bulut</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Duygu</surname>
<given-names>F</given-names></string-name>, <etal>et al.</etal>
<article-title>Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: a multicentre retrospective cross-sectional study.</article-title>
<source>Clin Microbiol Infect</source>. <year>2016</year>;<volume>22</volume>:<fpage>387.e1</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmi.2015.11.024</pub-id><?supplied-pmid 26806137?><pub-id pub-id-type="pmid">26806137</pub-id></mixed-citation></ref><ref id="R11"><label>11. </label><mixed-citation publication-type="journal"><string-name><surname>Papa</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bino</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Llagami</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Brahimaj</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Papadimitriou</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Pavlidou</surname>
<given-names>V</given-names></string-name>, <etal>et al.</etal>
<article-title>Crimean-Congo hemorrhagic fever in Albania, 2001.</article-title>
<source>Eur J Clin Microbiol Infect Dis</source>. <year>2002</year>;<volume>21</volume>:<fpage>603</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/s10096-002-0770-9</pub-id><?supplied-pmid 12226691?><pub-id pub-id-type="pmid">12226691</pub-id></mixed-citation></ref><ref id="R12"><label>12. </label><mixed-citation publication-type="journal"><string-name><surname>Harxhi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pilaca</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Delia</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Pano</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Rezza</surname>
<given-names>G</given-names></string-name>. <article-title>Crimean-Congo hemorrhagic fever: a case of nosocomial transmission.</article-title>
<source>Infection</source>. <year>2005</year>;<volume>33</volume>:<fpage>295</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/s15010-005-4129-x</pub-id><?supplied-pmid 16091904?><pub-id pub-id-type="pmid">16091904</pub-id></mixed-citation></ref><ref id="R13"><label>13. </label><mixed-citation publication-type="journal"><string-name><surname>Fisher-Hoch</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Khan</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Rehman</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mirza</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Khurshid</surname>
<given-names>M</given-names></string-name>, <string-name><surname>McCormick</surname>
<given-names>JB</given-names></string-name>. <article-title>Crimean Congo-haemorrhagic fever treated with oral ribavirin.</article-title>
<source>Lancet</source>. <year>1995</year>;<volume>346</volume>:<fpage>472</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(95)91323-8</pub-id><?supplied-pmid 7637481?><pub-id pub-id-type="pmid">7637481</pub-id></mixed-citation></ref><ref id="R14"><label>14. </label><mixed-citation publication-type="journal"><string-name><surname>Altaf</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Luby</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ahmed</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Zaidi</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Khan</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Mirza</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal>
<article-title>Outbreak of Crimean-Congo haemorrhagic fever in Quetta, Pakistan: contact tracing and risk assessment.</article-title>
<source>Trop Med Int Health</source>. <year>1998</year>;<volume>3</volume>:<fpage>878</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-3156.1998.00318.x</pub-id><?supplied-pmid 9855399?><pub-id pub-id-type="pmid">9855399</pub-id></mixed-citation></ref><ref id="R15"><label>15. </label><mixed-citation publication-type="journal"><string-name><surname>Swanepoel</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Shepherd</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Leman</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Shepherd</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>McGillivray</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Erasmus</surname>
<given-names>MJ</given-names></string-name>, <etal>et al.</etal>
<article-title>Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa.</article-title>
<source>Am J Trop Med Hyg</source>. <year>1987</year>;<volume>36</volume>:<fpage>120</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.1987.36.120</pub-id><?supplied-pmid 3101525?><pub-id pub-id-type="pmid">3101525</pub-id></mixed-citation></ref><ref id="R16"><label>16. </label><mixed-citation publication-type="journal"><string-name><surname>van de Wal</surname>
<given-names>BW</given-names></string-name>, <string-name><surname>Joubert</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>van Eeden</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>King</surname>
<given-names>JB</given-names></string-name>. <article-title>A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part IV. Preventive and prophylactic measures.</article-title>
<source>S Afr Med J</source>. <year>1985</year>;<volume>68</volume>:<fpage>729</fpage>&#x02013;<lpage>32</lpage>.<?supplied-pmid 2414853?><pub-id pub-id-type="pmid">2414853</pub-id></mixed-citation></ref><ref id="R17"><label>17. </label><mixed-citation publication-type="journal"><string-name><surname>Mishra</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Mehta</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mourya</surname>
<given-names>DT</given-names></string-name>, <string-name><surname>Gandhi</surname>
<given-names>S</given-names></string-name>. <article-title>Crimean-Congo haemorrhagic fever in India.</article-title>
<source>Lancet</source>. <year>2011</year>;<volume>378</volume>:<fpage>372</fpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(11)60680-6</pub-id><?supplied-pmid 21784269?><pub-id pub-id-type="pmid">21784269</pub-id></mixed-citation></ref><ref id="R18"><label>18. </label><mixed-citation publication-type="journal"><string-name><surname>Patel</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Patel</surname>
<given-names>KK</given-names></string-name>, <string-name><surname>Mehta</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Parikh</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Toshniwal</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Patel</surname>
<given-names>K</given-names></string-name>. <article-title>First Crimean-Congo hemorrhagic fever outbreak in India.</article-title>
<source>J Assoc Physicians India</source>. <year>2011</year>;<volume>59</volume>:<fpage>585</fpage>&#x02013;<lpage>9</lpage>.<?supplied-pmid 22334974?><pub-id pub-id-type="pmid">22334974</pub-id></mixed-citation></ref><ref id="R19"><label>19. </label><mixed-citation publication-type="journal"><string-name><surname>Stewart</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Clarke</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rovers</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Riley</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Simmonds</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Stewart</surname>
<given-names>G</given-names></string-name>, <etal>et al.</etal>; <collab>PRISMA-IPD Development Group</collab>. <article-title>Preferred reporting items for systematic review and meta-analyses of individual participant data. The PRISMA-IPD statement.</article-title>
<source>JAMA</source>. <year>2015</year>;<volume>313</volume>:<fpage>1657</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2015.3656</pub-id><?supplied-pmid 25919529?><pub-id pub-id-type="pmid">25919529</pub-id></mixed-citation></ref><ref id="R20"><label>20. </label><mixed-citation publication-type="confproc"><string-name><surname>Bulut</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Yilmaz</surname>
<given-names>GR</given-names></string-name>, <string-name><surname>Karakoc</surname>
<given-names>E</given-names></string-name>, <string-name><surname>&#x000d6;nde</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Kocak Tufan</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Demir&#x000f6;z</surname>
<given-names>AP</given-names></string-name>. Risk of Crimean-Congo haemorrhagic fever among healthcare workers. Presented at: 19th European Congress of Clinical Microbiology and Infectious Diseases; May 16&#x02013;19, <year>2009</year>; Helsinki, Finland.</mixed-citation></ref><ref id="R21"><label>21. </label><mixed-citation publication-type="journal"><string-name><surname>Guven</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Talan</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Altintas</surname>
<given-names>ND</given-names></string-name>, <string-name><surname>Memikoglu</surname>
<given-names>KO</given-names></string-name>, <string-name><surname>Yoruk</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Azap</surname>
<given-names>A</given-names></string-name>. <article-title>An unexpected fatal CCHF case and management of exposed health care workers.</article-title>
<source>Int J Infect Dis</source>. <year>2017</year>;<volume>55</volume>:<fpage>118</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2016.12.026</pub-id><?supplied-pmid 28069471?><pub-id pub-id-type="pmid">28069471</pub-id></mixed-citation></ref><ref id="R22"><label>22. </label><mixed-citation publication-type="journal"><string-name><surname>Parlak</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Ert&#x000fc;rk</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ko&#x0015f;an</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Parlak</surname>
<given-names>M</given-names></string-name>, <string-name><surname>&#x000d6;zkurt</surname>
<given-names>Z</given-names></string-name>. <article-title>A nosocomial outbreak of Crimean-Congo hemorrhagic fever.</article-title>
<source>J Microbiol Infect Dis.</source>
<year>2015</year>;<volume>5</volume>:<fpage>5</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.5799/ahinjs.02.2015.01.0166</pub-id></mixed-citation></ref><ref id="R23"><label>23. </label><mixed-citation publication-type="journal"><string-name><surname>Yildirmak</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tulek</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Bulut</surname>
<given-names>C</given-names></string-name>. <article-title>Crimean-Congo haemorrhagic fever: transmission to visitors and healthcare workers.</article-title>
<source>Infection</source>. <year>2016</year>;<volume>44</volume>:<fpage>687</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s15010-016-0923-x</pub-id><?supplied-pmid 27384066?><pub-id pub-id-type="pmid">27384066</pub-id></mixed-citation></ref><ref id="R24"><label>24. </label><mixed-citation publication-type="journal"><string-name><surname>T&#x000fc;t&#x000fc;nc&#x000fc;</surname>
<given-names>EE</given-names></string-name>, <string-name><surname>Gurbuz</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ozturk</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Kuscu</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Sencan</surname>
<given-names>I</given-names></string-name>. <article-title>Crimean Congo haemorrhagic fever, precautions and ribavirin prophylaxis: a case report.</article-title>
<source>Scand J Infect Dis</source>. <year>2009</year>;<volume>41</volume>:<fpage>378</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1080/00365540902882434</pub-id><?supplied-pmid 19343611?><pub-id pub-id-type="pmid">19343611</pub-id></mixed-citation></ref><ref id="R25"><label>25. </label><mixed-citation publication-type="journal"><string-name><surname>Sunbul</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Esen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Fletcher</surname>
<given-names>TE</given-names></string-name>, <string-name><surname>Dilek</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Guler</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Beeching</surname>
<given-names>NJ</given-names></string-name>, <etal>et al.</etal>
<article-title>A fatal case of healthcare associated Crimean-Congo haemorrhagic fever with severe disease and multi-organ failure.</article-title>
<source>J Infect</source>. <year>2016</year>;<volume>72</volume>:<fpage>253</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2015.10.005</pub-id><?supplied-pmid 26493271?><pub-id pub-id-type="pmid">26493271</pub-id></mixed-citation></ref><ref id="R26"><label>26. </label><mixed-citation publication-type="journal"><string-name><surname>Burney</surname>
<given-names>MI</given-names></string-name>, <string-name><surname>Ghafoor</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Saleen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Webb</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Casals</surname>
<given-names>J</given-names></string-name>. <article-title>Nosocomial outbreak of viral hemorrhagic fever caused by Crimean Hemorrhagic fever-Congo virus in Pakistan, January 1976.</article-title>
<source>Am J Trop Med Hyg</source>. <year>1980</year>;<volume>29</volume>:<fpage>941</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.1980.29.941</pub-id><?supplied-pmid 7435795?><pub-id pub-id-type="pmid">7435795</pub-id></mixed-citation></ref><ref id="R27"><label>27. </label><mixed-citation publication-type="journal"><string-name><surname>Bangash</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Khan</surname>
<given-names>EA</given-names></string-name>. <article-title>Treatment and prophylaxis with ribavirin for Crimean-Congo Hemorrhagic Fever&#x02014;is it effective?</article-title>
<source>J Pak Med Assoc</source>. <year>2003</year>;<volume>53</volume>:<fpage>39</fpage>&#x02013;<lpage>41</lpage>.<?supplied-pmid 12666854?><pub-id pub-id-type="pmid">12666854</pub-id></mixed-citation></ref><ref id="R28"><label>28. </label><mixed-citation publication-type="journal"><string-name><surname>Athar</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Baqai</surname>
<given-names>HZ</given-names></string-name>, <string-name><surname>Ahmad</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Khalid</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Bashir</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ahmad</surname>
<given-names>AM</given-names></string-name>, <etal>et al.</etal>
<article-title>Short report: Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan, February 2002.</article-title>
<source>Am J Trop Med Hyg</source>. <year>2003</year>;<volume>69</volume>:<fpage>284</fpage>&#x02013;<lpage>7</lpage>.<?supplied-pmid 14628945?><pub-id pub-id-type="pmid">14628945</pub-id></mixed-citation></ref><ref id="R29"><label>29. </label><mixed-citation publication-type="journal"><string-name><surname>Hasan</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Mahmood</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Jamil</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Atkinson</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Mohammed</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Samreen</surname>
<given-names>A</given-names></string-name>, <etal>et al.</etal>
<article-title>Crimean-Congo hemorrhagic fever nosocomial infection in a immunosuppressed patient, Pakistan: case report and virological investigation.</article-title>
<source>J Med Virol</source>. <year>2013</year>;<volume>85</volume>:<fpage>501</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.23473</pub-id><?supplied-pmid 23172105?><pub-id pub-id-type="pmid">23172105</pub-id></mixed-citation></ref><ref id="R30"><label>30. </label><mixed-citation publication-type="journal"><string-name><surname>Yadav</surname>
<given-names>PD</given-names></string-name>, <string-name><surname>Patil</surname>
<given-names>DY</given-names></string-name>, <string-name><surname>Shete</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Kokate</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Goyal</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Jadhav</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal>
<article-title>Nosocomial infection of CCHF among health care workers in Rajasthan, India.</article-title>
<source>BMC Infect Dis</source>. <year>2016</year>;<volume>16</volume>:<fpage>624</fpage>. <pub-id pub-id-type="doi">10.1186/s12879-016-1971-7</pub-id><?supplied-pmid 27809807?><pub-id pub-id-type="pmid">27809807</pub-id></mixed-citation></ref><ref id="R31"><label>31. </label><mixed-citation publication-type="journal"><string-name><surname>Yadav</surname>
<given-names>PD</given-names></string-name>, <string-name><surname>Raut</surname>
<given-names>CG</given-names></string-name>, <string-name><surname>Mourya</surname>
<given-names>DT</given-names></string-name>. <article-title>Re-occurrence of Crimean-Congo haemorrhagic fever in Ahmedabad, Gujarat, India (2012): a fatal case report.</article-title>
<source>Indian J Med Res</source>. <year>2013</year>;<volume>138</volume>:<fpage>1027</fpage>&#x02013;<lpage>8</lpage>.<?supplied-pmid 24521654?><pub-id pub-id-type="pmid">24521654</pub-id></mixed-citation></ref><ref id="R32"><label>32. </label><mixed-citation publication-type="journal"><string-name><surname>Jamil</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Hasan</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Sarwari</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Burton</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Hewson</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Clegg</surname>
<given-names>C</given-names></string-name>. <article-title>Crimean-Congo hemorrhagic fever: experience at a tertiary care hospital in Karachi, Pakistan.</article-title>
<source>Trans R Soc Trop Med Hyg</source>. <year>2005</year>;<volume>99</volume>:<fpage>577</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.trstmh.2005.03.002</pub-id><?supplied-pmid 15935414?><pub-id pub-id-type="pmid">15935414</pub-id></mixed-citation></ref><ref id="R33"><label>33. </label><mixed-citation publication-type="journal"><string-name><surname>Naderi</surname>
<given-names>HR</given-names></string-name>, <string-name><surname>Sarvghad</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Bojdy</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hadizadeh</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Sadeghi</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Sheybani</surname>
<given-names>F</given-names></string-name>. <article-title>Nosocomial outbreak of Crimean-Congo haemorrhagic fever.</article-title>
<source>Epidemiol Infect</source>. <year>2011</year>;<volume>139</volume>:<fpage>862</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1017/S0950268810002001</pub-id><?supplied-pmid 20800007?><pub-id pub-id-type="pmid">20800007</pub-id></mixed-citation></ref><ref id="R34"><label>34. </label><mixed-citation publication-type="journal"><string-name><surname>Naderi</surname>
<given-names>HR</given-names></string-name>, <string-name><surname>Sheybani</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Bojdi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Khosravi</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Mostafavi</surname>
<given-names>I</given-names></string-name>. <article-title>Fatal nosocomial spread of Crimean-Congo hemorrhagic fever with very short incubation period.</article-title>
<source>Am J Trop Med Hyg</source>. <year>2013</year>;<volume>88</volume>:<fpage>469</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.2012.12-0337</pub-id><?supplied-pmid 23269658?><pub-id pub-id-type="pmid">23269658</pub-id></mixed-citation></ref><ref id="R35"><label>35. </label><mixed-citation publication-type="journal"><string-name><surname>Mardani</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Keshtkar-Jahromi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ataie</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Adibi</surname>
<given-names>P</given-names></string-name>. <article-title>Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran.</article-title>
<source>Am J Trop Med Hyg</source>. <year>2009</year>;<volume>81</volume>:<fpage>675</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.2009.09-0051</pub-id><?supplied-pmid 19815885?><pub-id pub-id-type="pmid">19815885</pub-id></mixed-citation></ref><ref id="R36"><label>36. </label><mixed-citation publication-type="journal"><string-name><surname>Chinikar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Shayesteh</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Khakifirouz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Jalali</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Rasi Varaie</surname>
<given-names>FS</given-names></string-name>, <string-name><surname>Rafigh</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal>
<article-title>Nosocomial infection of Crimean-Congo haemorrhagic fever in eastern Iran: case report.</article-title>
<source>Travel Med Infect Dis</source>. <year>2013</year>;<volume>11</volume>:<fpage>252</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.tmaid.2012.11.009</pub-id><?supplied-pmid 23266037?><pub-id pub-id-type="pmid">23266037</pub-id></mixed-citation></ref><ref id="R37"><label>37. </label><mixed-citation publication-type="journal"><string-name><surname>Tishkova</surname>
<given-names>FH</given-names></string-name>, <string-name><surname>Belobrova</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Valikhodzhaeva</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Atkinson</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Hewson</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Mullojonova</surname>
<given-names>M</given-names></string-name>. <article-title>Crimean-Congo hemorrhagic fever in Tajikistan.</article-title>
<source>Vector Borne Zoonotic Dis</source>. <year>2012</year>;<volume>12</volume>:<fpage>722</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1089/vbz.2011.0769</pub-id><?supplied-pmid 22217164?><pub-id pub-id-type="pmid">22217164</pub-id></mixed-citation></ref><ref id="R38"><label>38. </label><mixed-citation publication-type="journal"><string-name><surname>Suleiman</surname>
<given-names>MNEH</given-names></string-name>, <string-name><surname>Muscat-Baron</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Harries</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Satti</surname>
<given-names>AGO</given-names></string-name>, <string-name><surname>Platt</surname>
<given-names>GS</given-names></string-name>, <string-name><surname>Bowen</surname>
<given-names>ETW</given-names></string-name>, <etal>et al.</etal>
<article-title>Congo/Crimean haemorrhagic fever in Dubai. An outbreak at the Rashid Hospital.</article-title>
<source>Lancet</source>. <year>1980</year>;<volume>2</volume>:<fpage>939</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(80)92103-0</pub-id><?supplied-pmid 6107588?><pub-id pub-id-type="pmid">6107588</pub-id></mixed-citation></ref><ref id="R39"><label>39. </label><mixed-citation publication-type="journal"><string-name><surname>Nabeth</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Cheikh</surname>
<given-names>DO</given-names></string-name>, <string-name><surname>Lo</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Faye</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Vall</surname>
<given-names>IO</given-names></string-name>, <string-name><surname>Niang</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal>
<article-title>Crimean-Congo hemorrhagic fever, Mauritania.</article-title>
<source>Emerg Infect Dis</source>. <year>2004</year>;<volume>10</volume>:<fpage>2143</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3201/eid1012.040535</pub-id><?supplied-pmid 15663851?><pub-id pub-id-type="pmid">15663851</pub-id></mixed-citation></ref><ref id="R40"><label>40. </label><mixed-citation publication-type="webpage">ProMED-RUS. Crimean-Congo hemorrhagic fever-Kazakhstan (South Kazakhstan). ProMed. <year>2009</year> Jul 15 [cited 2016 Feb 21]. <ext-link ext-link-type="uri" xlink:href="http://www.promedmail.org/">http://www.promedmail.org/</ext-link>, archive no. 20090715.2529.</mixed-citation></ref><ref id="R41"><label>41. </label><mixed-citation publication-type="journal"><string-name><surname>Aradaib</surname>
<given-names>IE</given-names></string-name>, <string-name><surname>Erickson</surname>
<given-names>BR</given-names></string-name>, <string-name><surname>Mustafa</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Khristova</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Saeed</surname>
<given-names>NS</given-names></string-name>, <string-name><surname>Elageb</surname>
<given-names>RM</given-names></string-name>, <etal>et al.</etal>
<article-title>Nosocomial outbreak of Crimean-Congo hemorrhagic fever, Sudan.</article-title>
<source>Emerg Infect Dis</source>. <year>2010</year>;<volume>16</volume>:<fpage>837</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3201/eid1605.091815</pub-id><?supplied-pmid 20409377?><pub-id pub-id-type="pmid">20409377</pub-id></mixed-citation></ref><ref id="R42"><label>42. </label><mixed-citation publication-type="journal"><string-name><surname>Elata</surname>
<given-names>AT</given-names></string-name>, <string-name><surname>Karsany</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Elageb</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Hussain</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Eltom</surname>
<given-names>KH</given-names></string-name>, <string-name><surname>Elbashir</surname>
<given-names>MI</given-names></string-name>, <etal>et al.</etal>
<article-title>A nosocomial transmission of crimean-congo hemorrhagic fever to an attending physician in North Kordufan, Sudan.</article-title>
<source>Virol J</source>. <year>2011</year>;<volume>8</volume>:<fpage>303</fpage>. <pub-id pub-id-type="doi">10.1186/1743-422X-8-303</pub-id><?supplied-pmid 21672268?><pub-id pub-id-type="pmid">21672268</pub-id></mixed-citation></ref><ref id="R43"><label>43. </label><mixed-citation publication-type="journal"><string-name><surname>Bente</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Forrester</surname>
<given-names>NL</given-names></string-name>, <string-name><surname>Watts</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>McAuley</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Whitehouse</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Bray</surname>
<given-names>M</given-names></string-name>. <article-title>Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity.</article-title>
<source>Antiviral Res</source>. <year>2013</year>;<volume>100</volume>:<fpage>159</fpage>&#x02013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2013.07.006</pub-id><?supplied-pmid 23906741?><pub-id pub-id-type="pmid">23906741</pub-id></mixed-citation></ref><ref id="R44"><label>44. </label><mixed-citation publication-type="journal"><string-name><surname>Ince</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yasa</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Metin</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sonmez</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Meram</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Benkli</surname>
<given-names>B</given-names></string-name>, <etal>et al.</etal>
<article-title>Crimean-Congo hemorrhagic fever infections reported by ProMED.</article-title>
<source>Int J Infect Dis</source>. <year>2014</year>;<volume>26</volume>:<fpage>44</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2014.04.005</pub-id><?supplied-pmid 24947424?><pub-id pub-id-type="pmid">24947424</pub-id></mixed-citation></ref><ref id="R45"><label>45. </label><mixed-citation publication-type="journal"><string-name><surname>Dokuzoguz</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Celikbas</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>G&#x000f6;k</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Baykam</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Eroglu</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Erg&#x000f6;n&#x000fc;l</surname>
<given-names>&#x000d6;</given-names></string-name>. <article-title>Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality.</article-title>
<source>Clin Infect Dis</source>. <year>2013</year>;<volume>57</volume>:<fpage>1270</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1093/cid/cit527</pub-id><?supplied-pmid 23946218?><pub-id pub-id-type="pmid">23946218</pub-id></mixed-citation></ref><ref id="R46"><label>46. </label><mixed-citation publication-type="journal"><string-name><surname>Ergonul</surname>
<given-names>O</given-names></string-name>. <article-title>Treatment of Crimean-Congo hemorrhagic fever.</article-title>
<source>Antiviral Res</source>. <year>2008</year>;<volume>78</volume>:<fpage>125</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2007.11.002</pub-id><?supplied-pmid 18096251?><pub-id pub-id-type="pmid">18096251</pub-id></mixed-citation></ref><ref id="R47"><label>47. </label><mixed-citation publication-type="journal"><string-name><surname>Ergonul</surname>
<given-names>O</given-names></string-name>. <article-title>DEBATE (see Elaldi N et al, Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. Journal of Infection 2009; 58: 238-244): Biases and misinterpretation in the assessment of the efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever.</article-title>
<source>J Infect</source>. <year>2009</year>;<volume>59</volume>:<fpage>284</fpage>&#x02013;<lpage>6, author reply 286&#x02013;9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2009.08.006</pub-id><?supplied-pmid 19699762?><pub-id pub-id-type="pmid">19699762</pub-id></mixed-citation></ref><ref id="R48"><label>48. </label><mixed-citation publication-type="journal"><string-name><surname>Pourahmad</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Raoofi</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Chinikar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ghiasi</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Ghalyanchi-Langeroudi</surname>
<given-names>A</given-names></string-name>. <article-title>Nosocomial transmission of Crimean-Congo hemorrhagic fever in a health care worker, Fars Province, Iran.</article-title>
<source>Iran J Clin Infect Dis.</source>
<year>2011</year>;<volume>6</volume>:<fpage>47</fpage>&#x02013;<lpage>50</lpage>.</mixed-citation></ref><ref id="R49"><label>49. </label><mixed-citation publication-type="journal"><string-name><surname>Ergonul</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Zeller</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Celikbas</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Dokuzoguz</surname>
<given-names>B</given-names></string-name>. <article-title>The lack of Crimean-Congo hemorrhagic fever virus antibodies in healthcare workers in an endemic region.</article-title>
<source>Int J Infect Dis</source>. <year>2007</year>;<volume>11</volume>:<fpage>48</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2005.10.009</pub-id><?supplied-pmid 16600655?><pub-id pub-id-type="pmid">16600655</pub-id></mixed-citation></ref><ref id="R50"><label>50. </label><mixed-citation publication-type="journal"><string-name><surname>Mardani</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rahnavardi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rajaeinejad</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Naini</surname>
<given-names>KH</given-names></string-name>, <string-name><surname>Chinikar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pourmalek</surname>
<given-names>F</given-names></string-name>, <etal>et al.</etal>
<article-title>Crimean-Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions.</article-title>
<source>Am J Trop Med Hyg</source>. <year>2007</year>;<volume>76</volume>:<fpage>443</fpage>&#x02013;<lpage>5</lpage>.<?supplied-pmid 17360865?><pub-id pub-id-type="pmid">17360865</pub-id></mixed-citation></ref></ref-list></back></article>